HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots To Unload OTC Business, Citing Market Consolidation

This article was originally published in The Rose Sheet

Executive Summary

Merger and acquisition activity in the OTC drug industry has prompted Boots the Chemists to put its healthcare unit up for sale
Advertisement

Related Content

Reckitt Spends $3.3 Bil. On Boots, Gains Clearasil Anti-Acne Brand
Reckitt Spends $3.3 Bil. On Boots, Gains Clearasil Anti-Acne Brand
Boots first half
Boots first half
Boots Healthcare International
Boots Healthcare International
Bayer pondering Boots OTC buy?
Bayer pondering Boots OTC buy?
Mergers & Acquisitions In Brief
Boots OTC Division Sale To Be Completed In FY ’06, Execs Maintain
Advertisement
UsernamePublicRestriction

Register

RS012958

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel